# Combination Chemotherapy in Treating Patients With Advanced Cancer

> **NCT00021073** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 90 (estimated)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** alvocidib
- **DRUG:** leucovorin calcium
- **DRUG:** fluorouracil
- **DRUG:** irinotecan hydrochloride

## Key facts

- **NCT ID:** NCT00021073
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-05
- **Primary completion:** 2006-04
- **Final completion:** —
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2013-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00021073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00021073, "Combination Chemotherapy in Treating Patients With Advanced Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00021073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*